View in EDS HTML Full Text PDF Full Text

Targeting Drp1 inhibits ESCC progression via the ROS-PGC1-α-Nrf1/2 pathway.

Saved in:
Bibliographic Details
Title: Targeting Drp1 inhibits ESCC progression via the ROS-PGC1-α-Nrf1/2 pathway.
Authors: Jiang, Zhixiong1,2 (AUTHOR), Yang, Yating1,2 (AUTHOR), Zhou, Jinchi3 (AUTHOR), Li, Xin4 (AUTHOR), Meng, Qingqing1 (AUTHOR), Yu, Xiangyi1 (AUTHOR), Xue, Yaxin1 (AUTHOR), Li, Mengyu1 (AUTHOR), Cai, Yichen1 (AUTHOR), Han, Pengchun1 (AUTHOR), Jiang, Mingjun1 (AUTHOR), Wang, Huizhen1 (AUTHOR), Liu, Congrong1 (AUTHOR), Zhao, Jing1,2 (AUTHOR) zhaojing_hena@163.com, Wan, Lixin5 (AUTHOR) nanyang1967@163.com, Bao, Dengke1,2,6 (AUTHOR) dengkebao@henu.edu.cn
Source: Journal of Translational Medicine. 6/17/2025, Vol. 23 Issue 1, p1-17. 17p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14795876
DOI:10.1186/s12967-025-06697-8